The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic
inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration …

Diabetic foot ulceration is a major complication of diabetes mellitus. Recombinant human
epidermal growth factor (rhEGF) is used topically in the treatment of diabetic foot ulcers. This …

To investigate the efficacy and safety of recombinant human epidermal growth factor
(rhEGF) in advanced diabetic foot ulcers (DFU) A double‐blind trial was carried out to test …

Diabetic foot ulcer and its complications are becoming more and more serious problems
threatening people's health. In the last decade, multiple growth factors and their combined …

Objective: To evaluate the efficacy and safety of recombinant human epidermal growth factor
(rh‐EGF) in healing foot ulcers in diabetic patients. Methods: A total of 28 subjects with foot …

Fernández‐Montequín JI, Valenzuela‐Silva CM, González Díaz O, Savigne W, Sancho‐
Soutelo N, Rivero‐Fernández F, Sánchez‐Penton P, Morejón‐Vega L, Artaza‐Sanz H …

To validate the efficacy of recombinant human epidermal growth factor (hEGH) in healing
diabetic foot ulcers (DFUs) at biochemical and molecular levels. A total of 50 noninfected …

Objective: The aim of this study was to explore the clinical effects of intralesional
administration of an epidermal growth factor (EGF) up to complete wound closure. Methods …

Aims This study was conducted to evaluate the efficacy and safety of a novel spray-applied
growth factor therapy containing recombinant human epidermal growth factor (rhEGF) for the …

Background: Intralesional epidermal growth factor (EGF) has been available as a
medication in Turkey since 2012. We present the results of our experience using …